Individualized Exploration of Aerobic Exercise-assisted Treatment of Depression
1 other identifier
interventional
80
1 country
1
Brief Summary
The goal of this project is to quantify the relative effectiveness of aerobic exercise monitored by smart wristbands in assisting the treatment of depression and improving cognitive function. It aims to explore the mechanisms through which aerobic exercise exerts its effects using imaging genetics and other methods, and to identify suitable populations for exercise, ultimately providing personalized clinical exercise prescriptions. This study will intervene from a behavioral perspective and also seeks to motivate participants to change and improve their physical activity habits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2024
CompletedStudy Start
First participant enrolled
September 12, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedJuly 2, 2025
July 1, 2025
1.1 years
September 5, 2024
July 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in Hamilton Depression Rating Scale (HAMD)
The outcome is assessed by HAMD-17 Scale.
Week 4 and 8 of treatment duration
Secondary Outcomes (15)
Change from baseline in THINC-it score
Week 4 and 8 of treatment duration
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Week 4 and 8 of treatment duration
Response to treatment
Week 4 and 8 of treatment duration
Clinical Global Impression-Severity of Illness (CGI-S)
Week 4 and 8 of treatment duration
Change from baseline in Hamilton Anxiety Rating Scale (HAMA)
Week 4 and 8 of treatment duration
- +10 more secondary outcomes
Study Arms (2)
Aerobic exercise group
EXPERIMENTALAerobic exercise intervention combined with conventional drug treatment
Waiting control group
NO INTERVENTIONAntidepressants were routinely used and aerobic exercise interventions were performed at the end of the 8-week follow-up
Interventions
Moderate-intensity aerobic exercise for 30-50 minutes three times a week was added to usual medical therapy
Eligibility Criteria
You may qualify if:
- Aged 18-45 years (including 18 and 45), no gender restriction;
- Meets the diagnostic criteria for depressive disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V);
- Outpatients or inpatients; Hamilton Depression Rating Scale 17-item (HAMD-17) score ≥ 14; Mood Disorder Questionnaire (MDQ) screening negative to exclude bipolar disorder patients; and Clinical Global Impressions-Severity (CGI-S) score ≥ 4;
- Maintained on antidepressant treatment for at least 4 weeks or not using antidepressant treatment;
- Written informed consent obtained from the patient.
You may not qualify if:
- Diagnosed with other mental disorders, including schizophrenia, bipolar disorder, alcohol or substance abuse/dependence, eating disorders, etc.;
- Individuals with intellectual disabilities or who are unable to cooperate for other reasons, or those lacking or having incomplete civil capacity during the onset of illness;
- Suffering from neurological or organic brain diseases (such as stroke, cerebral hemorrhage, brain tumors, Parkinson's disease, epilepsy, etc.) and a history of severe traumatic brain injury;
- Suffering from conditions with high exercise risk, such as hypertension or heart disease;
- Currently undergoing systematic psychological therapy;
- In the 3-minute step test, males with a recovery heart rate more than131 and females with a recovery heart rate more than 140;
- Physically restricted individuals unable to participate in physical exercise;
- Physical Activity Readiness Questionnaire (PAR-Q) score ≥ 2;
- Pregnant women or individuals with contraindications to MRI examinations;
- Individuals with severe suicidal tendencies or at risk of harming others.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Sixth Hostipal
Beijing, Beijing Municipality, 100191, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 5, 2024
First Posted
September 19, 2024
Study Start
September 12, 2024
Primary Completion
October 30, 2025
Study Completion
December 30, 2025
Last Updated
July 2, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share